A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an ...

Why Is DexCom a Good Business? Founded in 1999 and receiving its first FDA approval in 2006, DexCom (NASDAQ:DXCM) develops ...

The S&P 500 SPX has risen 14.5% this year through Friday. All price changes in this article exclude dividends. Through Friday, 57% of stocks in the S&P 500 were up for 2025.

The Invesco QQQ ETF ($QQQ) rose by a modest 0.08% on Friday amid uncertainty over the Federal Reserve’s next policy decision ...

The S&P 1500 Health Care Index gained 1.9% in September, underperforming the S&P 500, which advanced 3.7%. Read more here.

DexCom (DXCM) just received FDA clearance for Smart Basal, a new device designed to help adults with Type 2 diabetes optimize their insulin dosing using personalized, real-time sensor data. This ...

DexCom receives FDA clearance for DexCom Smart Basal titration software module, which optimizes basal insulin dose in type 2 ...

These healthcare stocks have long-term and profitable growth runways.

Dexcom announced the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes will ...

The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that securities class action lawsuits have been ...

The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that securities class action lawsuits have been filed against DexCom, Inc. (“DexCom”) ( NASDAQ: DXCM) on behalf of those who ...

Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal ...